Значение202020212022202320242025Всего обязательств——————Общий капитал——————Всего обязательств и собственного капитала——————Общий долг——————Чистый долг——————
ProQR Therapeutics N.V
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.